Travere Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $7.4M | 525k | 13.99 |
| 2024-06-30 | $3.9M | 472k | 8.22 |
| 2024-03-31 | $3.2M | 417k | 7.71 |
| 2023-12-31 | $2.6M | 288k | 8.99 |
| 2023-09-30 | $2.6M | 291k | 8.94 |
| 2023-06-30 | $4.5M | 291k | 15.36 |
| 2023-03-31 | $6.2M | 277k | 22.49 |
| 2022-12-31 | $5.1M | 245k | 21.03 |
| 2022-09-30 | $6.1M | 247k | 24.64 |
| 2022-06-30 | $5.8M | 238k | 24.23 |
| 2022-03-31 | $6.1M | 236k | 25.77 |
| 2021-12-31 | $7.2M | 230k | 31.04 |
| 2021-09-30 | $4.1M | 168k | 24.25 |
| 2020-12-31 | $338k | 12k | 27.28 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management